21st Century Cures Initiative Could Boost Clinical Trials Enrollment
It’s Clinical Trials Awareness Week. And as patients, health care providers, researchers and industry promote the value of clinical trials participation, one coalition is asking the federal government to help solve clinical trials’ chronic under-enrollment.
IfPA Policy Brief Calls for Transparent Biosimilar Labeling
In the Institute for Patient Access’ new policy brief, “Informed Prescribing,” authors David Charles, MD, and Mary Ann Chapman, PhD, explain why biosimilar medications should come with transparent, accurate prescribing information.
U.S. Senators Question FDA’s “Placeholder” Biosimilar Naming Solution
The Food and Drug Administration’s distinct name for the first biosimilar was a “placeholder,” the agency declared on March 6.
Dormant Therapies’ Hidden Promise for Patients
The innovative therapies that some patients need already exist – but have been shelved by companies because they take too long and cost too much to develop.
Congress Urged to Prioritize Headache Research, Treatments
During today’s annual Headache on the Hill event, patients, physicians and advocates from the Alliance for Headache Disorders Advocacy will once again brief members of Congress on the impact of headache – and how better funding, more research and improved access to treatments could mitigate the conditions’ impact on patients.
Hepatitis Testing Bill Helps Patients Fight “Silent Killer”
Recently introduced federal legislation sets out to fight one of the nation’s “silent killers:” hepatitis.
AfPA Video Navigates Clinical Pathways’ Effect on Personalized Care
Will cost-focused clinical pathways derail personalized health care? A newly released video from the Alliance for Patient Access explores this question by considering how clinical pathways affect patients, their care regimen and their relationship with their health care providers.
Coverage Details Elude ACA Exchange Patients, New Study Reports
Patients using a state or the federal health care exchange want basic details about their coverage plan: which providers are in network, what co-pay requirements exist and which medications are covered.
As Cost Debate Persists, Hepatitis C Patients Go Untreated
Expensive new therapies to cure hepatitis C are racking up big bills for Medicare and state Medicaid programs.
Alliance for Patient Access Assumes Leadership of Rx Process Website
The Alliance for Patient Access (AfPA) today announced that it will now manage www.PrescriptionProcess.com, an online resource for patients to learn, share stories and advocate about access to approved medical therapies.
